Users Discontinuing Weight-Loss Medications Regain Pounds Four Times Faster Compared to People Using Diet and Exercise

A recent study suggests that people who discontinue popular weight-loss injections like Mounjaro or Wegovy may regain reduced body mass at a significantly accelerated pace than those who stop traditional lifestyle programs.

Findings released in a leading medical journal demonstrates that while overweight individuals often shed a large proportion of their total mass while on the medication, the weight returns at an average rate of nearly a kilo each month upon discontinuation.

"Individuals using such treatments must be informed of the potential of rapid rebound weight gain when the therapy concludes," warns lead investigator Dr. Susan Jebb.

Such speed of regain suggests a reversion to starting weight in about a year and a half.

Comparing Therapies

The study, which examined 37 of trials involving thousands of patients, compared the outcomes of the injectable medications with conventional dieting.

The team point out that individuals who lose weight through dieting generally see a more gradual creep back—around 100 grams monthly—once they finish.

Explaining the Rapid Regain

Doctors believe the mode of action of the injections explains the amplified weight return.

These medications copy a body's own chemical called GLP-1, which moderates feelings of fullness.

"Sustained high doses of the hormone concentrations far above than normal could lead to the body to produce less of its own natural hormone, and could lessen sensitivity to its actions," noted Dr. Adam Collins, a nutrition specialist.

"Discontinuation of this hormone supplement leads to appetite is uncontrolled, making binge eating much more probable."

A Chronic Issue?

Health authorities recommend the injections for individuals with weight-linked medical conditions, accompanied by recommended lifestyle changes.

Professionals argue that, considering the significant potential of weight regain, the therapy might need to be life-long.

This opinion is reinforced by pharmaceutical companies, who state that the results "underscore the long-term character of obesity," akin to managing diseases like high blood pressure.

Patient Experiences

Users who have come off the jabs describe a intense resurgence of appetite.

"I experienced something flipping and I was suddenly ravenous," said an individual.

The struggle is compounded if patients have not developed permanent dietary or behavioural modifications during therapy.

Widespread Interest

Survey data indicate that millions of adults in the UK have used weight-loss jabs in the past year, with interest remaining high.

• Adoption is higher among females than males.
• The middle-aged demographic shows the highest level of interest.
• A large proportion access the medications through private prescriptions rather than the NHS.

In conclusion, researchers emphasize that while these medications are potent tools for weight loss, they are not a magic solution and lasting health benefits likely depends on ongoing behavioural changes.